Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine
Ryutaro Kotaki, Yu Adachi, Saya Moriyama, et al.
Science Immunology (2022) Vol. 7, Iss. 70
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 471
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
Jasmin Quandt, Alexander Muik, Nadine Salisch, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 187
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
Rishi R. Goel, Mark M. Painter, Kendall A. Lundgreen, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1875-1887.e8
Open Access | Times Cited: 177
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection
Chengzi I. Kaku, Alan Bergeron, Clas Ahlm, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 116
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
Shô Miyamoto, Takeshi Arashiro, Yu Adachi, et al.
Med (2022) Vol. 3, Iss. 4, pp. 249-261.e4
Open Access | Times Cited: 69
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
Hassen Kared, Asia‐Sophia Wolf, Amin Alirezaylavasani, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant
Aurélien Sokal, Matteo Broketa, Giovanna Barba‐Spaeth, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1096-1104.e4
Open Access | Times Cited: 51
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine
Prabhu S. Arunachalam, Yupeng Feng, Usama Ashraf, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 658
Open Access | Times Cited: 50
Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions
Fahadul Islam, Manish Dhawan, Mohamed H. Nafady, et al.
Annals of Medicine and Surgery (2022) Vol. 78
Open Access | Times Cited: 47
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
Clarisa M. Buckner, Lela Kardava, Omar El Merhebi, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4333-4346.e14
Open Access | Times Cited: 45
Recent insights into SARS‐CoV‐2 omicron variant
Severino Jefferson Ribeiro da Silva, Alain Kohl, Lindomar Pena, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 43
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Toon Braeye, Lucy Catteau, Ruben Brondeel, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3292-3300
Open Access | Times Cited: 37
Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain
Leerang Yang, Matthew Van Beek, Zijun Wang, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112256-112256
Open Access | Times Cited: 34
Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination
Véronique Barateau, Loïc Peyrot, Carla Saade, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 687
Open Access | Times Cited: 23
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron
Hye‐Kyung Lee, Ludwig Knabl, Juan I. Moliva, et al.
Cell Reports (2022) Vol. 39, Iss. 2, pp. 110680-110680
Open Access | Times Cited: 31
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2
Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2724-2734
Open Access | Times Cited: 31
Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees
Takeshi Inoue, Ryo Shinnakasu, Kawai Chie, et al.
The Journal of Experimental Medicine (2022) Vol. 220, Iss. 2
Open Access | Times Cited: 31
Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
Zhonghao Chen, Ying Zhang, Meng Wang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4629-4641
Open Access | Times Cited: 30
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
Saya Moriyama, Yuki Anraku, Shunta Taminishi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease
Chunsong Hu
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines
Ki Hyun Bae, Bhuvaneshwari D O Shunmuganathan, Li Zhang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top